Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort

European Urology

Volumn 66, Issue 1, 2014, Pages 156-163

  Aziz, Atiqullah ^a   May, Matthias ^b   Burger, Maximilian ^a   Palisaar, Rein Jüri ^c   Trinh, Quoc Dien ^d   Fritsche, Hans Martin ^a   Rink, Michael ^e   Chun, Felix ^e   Martini, Thomas ^f   Bolenz, Christian ^f   Mayr, Roman ^g   Pycha, Armin ^g   Nuhn, Philipp ^h   Stief, Christian ^h   Novotny, Vladimir ⁱ   Wirth, Manfred ⁱ   Seitz, Christian ^j   Noldus, Joachim ^c   Gilfrich, Christian ^b   Shariat, Shahrokh F ^j   Brookman May, Sabine ^h   Bastian, Patrick J ^k   Denzinger, Stefan ^a   Gierth, Michael ^a   Roghmann, Florian ^c   more..

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Department of Urology   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g CENTRAL HOSPITAL OF BOLZANO   (Italy)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k Golzheim Paracelsus Clinic   (Germany)

more..

Author keywords

90 day mortality; Bladder cancer; Nomogram; Outcome; Radical cystectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURGERY; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CYSTECTOMY; DISTANT METASTASIS; FEMALE; HUMAN; ISBARN NOMOGRAM; LENGTH OF STAY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NOMOGRAM; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL PREDICTION; VALIDATION STUDY; AREA UNDER THE CURVE; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; EPIDEMIOLOGY; EUROPE; HEALTH STATUS INDICATOR; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SECONDARY; URINARY BLADDER NEOPLASMS;

AGE FACTORS; AGED; AREA UNDER CURVE; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CYSTECTOMY; EUROPE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NOMOGRAMS; PROBABILITY; PROSPECTIVE STUDIES; ROC CURVE; URINARY BLADDER NEOPLASMS;

EID: 84902084243     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.12.018     Document Type: Article

References (29)

1. A. Stenzl, N.C. Cowan, and M. De Santis et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009 1018
2. V. Novotny, O.W. Hakenberg, and D. Wiessner et al. Perioperative complications of radical cystectomy in a contemporary series Eur Urol 51 2007 397 402 (Pubitemid 44937782)
3. A. Shabsigh, R. Korets, and K.C. Vora et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology Eur Urol 55 2009 164 176
4. B.R. Konety, V. Allareddy, and H. Herr Complications after radical cystectomy: analysis of population-based data Urology 68 2006 58 64 (Pubitemid 44037723)
5. B.K. Hollenbeck, D.C. Miller, and D. Taub et al. Identifying risk factors for potentially avoidable complications following radical cystectomy J Urol 174 2005 1231 1237 discussion 1237 (Pubitemid 41318688)
6. G. Novara, V. De Marco, and M. Aragona et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer J Urol 182 2009 914 921
7. R. Mayr, M. May, and T. Martini et al. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder BJU Int 110 2012 222 227
8. Roghmann F, Trinh QD, Braun K, et al. Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol. In press. http://dx.doi.org/10.1111/iju.12232
9. M.L. Quek, J.P. Stein, and S. Daneshmand et al. A critical analysis of perioperative mortality from radical cystectomy J Urol 175 2006 886 890
10. M.P. Porter, J.L. Gore, and J.L. Wright Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study World J Urol 29 2011 73 77
11. R. Schiavina, M. Borghesi, and M. Guidi et al. Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology Clin Genitourin Cancer 11 2013 189 197
12. R.C.G. Martin, M.F. Brennan, and D.P. Jaques Quality of complication reporting in the surgical literature Ann Surg 235 2002 803 813 (Pubitemid 34547298)
13. S.M. Prasad, M. Ferreria, and A.M. Berry et al. Surgical Apgar outcome score: 21 perioperative risk assessment for radical cystectomy J Urol 181 2009 1046 1052
14. M.C. Smaldone, A.T. Corcoran, and M. Hayn et al. Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equations J Urol 182 2009 2619 2624
15. H. Isbarn, C. Jeldres, and L. Zini et al. A population based assessment of perioperative mortality after cystectomy for bladder cancer J Urol 182 2009 70 77
16. J.M. Taylor, A. Feifer, and C.J. Savage et al. Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer BJU Int 109 2012 855 859
17. S.M. Donat, T. Siegrist, A. Cronin, C. Savage, M.I. Milowsky, and H.W. Herr Radical cystectomy in octogenarians - does morbidity outweigh the potential survival benefits? J Urol 183 2010 2171 2177
18. F.L. Greene, M. Gospodarowicz, and C. Wittekend et al. American Joint Committee on Cancer (AJCC) staging manual ed. 7. 2009 Springer Philadelphia, PA
19. N. Hens, M. Aerts, and G. Molenberghs Model selection for incomplete and design-based samples Stat Med 25 2006 2502
20. A.S. Elstein Heuristics and biases: selected errors in clinical reasoning Acad Med 74 1999 791 794 (Pubitemid 29344140)
21. I. Vlaev, and N. Chater Game relativity: how context influences strategic decision making J Exp Psychol Learn Mem Cogn 32 2006 131 149 (Pubitemid 43283752)
22. M.W. Kattan Nomograms. Introduction Semin Urol Oncol 20 2002 79 81
23. R.M. Hogarth, and N. Karelaia Heuristic and linear models of judgment: matching rules and environments Psychol Rev 114 2007 733 758
24. S.F. Shariat, V. Margulis, Y. Lotan, F. Montorsi, and P.I. Karakiewicz Nomograms for bladder cancer Eur Urol 54 2008 41 53
25. P. Nuhn, M. May, and M. Sun et al. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder Eur Urol 61 2012 58 64
26. A.A. Gawande, M.R. Kwaan, S.E. Regenbogen, S.A. Lipsitz, and M.J. Zinner An Apgar score for surgery J Am Coll Surg 204 2007 201 208 (Pubitemid 46124056)
27. G.P. Copeland, D. Jones, and M. Walters POSSUM: a scoring system for surgical audit Br J Surg 78 1991 355 360
28. T.M. Morgan, K.A. Keegan, and D.A. Barocas et al. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy J Urol 186 2011 829 834
29. M. Burger, P. Mulders, and W. Witjes Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire Eur Urol 61 2012 1070 1071